Latest Heartware International (HTWR)

New Post Public Reply Private Reply Replies (0) Message Board

Mar 13, 2014 at 9:35 AM

Latest Heartware International (HTWR) Headlines

HeartWare Presentation At The 2014 Barclays Global Healthcare Conference To Be Webcast
PR Newswire - Fri Mar 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel.

Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday

HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.

HeartWare International Reports Fourth Quarter 2013 Results
PR Newswire - Thu Feb 27, 6:00AM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $53.1 million for the fourth quarter ended December 31, 2013, a 62% increase compared to $32.7 million in revenue for the same period of 2012. For the fiscal year 2013, the company generated revenue of $207.9 million, an 87% increase compared to revenue of $110.9 million in fiscal year 2012.

HeartWare Presentation At The Raymond James 35th Annual Institutional Investors Conference To Be Webcast
PR Newswire - Wed Feb 26, 3:00PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande Lakes, Orlando, Florida.

Insider Trading Alert - HTWR, IDTI And RFMD Traded By Insiders
at The Street - Tue Feb 18, 9:30AM CST
Stocks with insider trader activity include HTWR, IDTI and RFMD

HeartWare Schedules Fourth Quarter Conference Call And Webcast
PR Newswire - Tue Feb 04, 4:21PM CST
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time on Thursday, February 27, 2014. The Company plans to release the financial results prior to the conference call.

HeartWare Presentation At The 2014 Leerink Global Healthcare Conference To Be Webcast
PR Newswire - Tue Feb 04, 2:00PM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York City.

29.9% Return Seen to Date on SmarTrend HeartWare International Call (HTWR)
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 29.87% as of today's recent price of $99.90.

Uptrend Call Working As HeartWare International Stock Rises 34.9% (HTWR)
Comtex SmarTrend(R) - Wed Jan 22, 9:20AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.86% as of today's recent price of $103.74.

HEARTWARE
at Investor's Business Daily - Tue Jan 14, 5:46PM CST
HEARTWARE (HTWR), an implantable heart-pump maker, said preliminary Q4 sales were $53 mil, up 62%, but below views for $58.4 mil. Shares dropped 9.9% to 93.

HeartWare gives weak revenue guidance
AP - Tue Jan 14, 5:07PM CST
FRAMINGHAM, Mass. (AP) — HeartWare International Inc. shares sank in after-hours trading Tuesday after the medical device company said that its revenue may fall short of market forecasts.

Shares of HTWR Up 34.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 14, 5:01PM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.22% as of today's recent price of $103.25.

HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
PR Newswire - Tue Jan 14, 3:45PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be approximately $53 million, bringing expected full-year 2013 revenues to approximately $208 million.

Abiomed, Inc.: The Best Medical Device Companies of 2013
Todd Campbell, The Motley Fool - Motley Fool - Thu Jan 09, 12:54PM CST
With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry performed well in 2013 -- but which stocks were the biggest winners? Some of the best performers outpaced the index significantly last...

Insider Trading Alert - PLCE, HTWR, MMM, P And IBKR Traded By Insiders
at The Street - Wed Jan 08, 10:01AM CST
Stocks with insider trader activity include PLCE, HTWR, MMM, P and IBKR

HeartWare International Has Returned 30.0% Since SmarTrend Recommendation (HTWR)
Comtex SmarTrend(R) - Tue Jan 07, 11:10AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 30.00% as of today's recent price of $100.00.

MedTech Industry Stock Update - Jan 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Industry Outlook

MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews

HeartWare International Up 20.8% Since SmarTrend Uptrend Call (HTWR)
Comtex SmarTrend(R) - Tue Dec 31, 9:31AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 2 months, HeartWare International has returned 20.75% as of today's recent price of $92.89.

HeartWare International (HTWR) Stock Research Links

HTWR Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cascades Eyes New Quebec Govt for Growth Partnerships

Quebec's New Ministers: A Fresh Start or the Same Old? So the suits in Quebec have shuffled about and Cascades Inc. (TSX: CAS)—a heavyweight in sustainable papermaking—is polishing their best handshake. They're rolling out the welcome mat for the new ministers in the Government of Quebec. As someone who've seen their fair share of this song and dance, the real...

Sivers Semiconductors Shakes Up Auditors and Incentives

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Procede Software Acquires RIMSS: Dealer Tech Shift?

Procede's Big Play Seems like Procede Software is tossing the dice with its latest move. The software scene for dealership management is as cutthroat as a New York deli lineup, and now we've got Procede moving to scoop up RIMSS. This isn't just a back-office shuffle; it's a world-rocking maneuver that brings decades of dealer technology know-how into one basket. What's...

Green Builder Media's Fresh Focus on Net Zero Homes

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Mercuryo's Swaps: A New Era in Crypto Trading Flexibility

Mercuryo's Bold Leap into Crypto Flexibility Mercuryo thinks they've got this crypto game figured out, tossing a curveball into the market with Swaps. It's like they're saying, "Here, make your moves without the usual headaches." Launched on October 22, 2026, this product lets folks trade between 38 digital tokens and struts out 700 possible trading pairs—and that's...

Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Granite Gives Pink Raises $583K for Cancer Research

Not Just About Numbers: Employee-Led Push for Health If you've ever doubted the power of collective purpose, take a look at Granite Telecommunications' recent endeavor. This hard-hitting telecom giant, with its robust footprint across North America's communication and tech sectors, isn't resting on its laurels when it comes to social responsibility. Their 'Granite Gives...

CobbleStone & Chu Chua Tech: A Transformative Alliance

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

QFIN Investors Eye Class Action Amid Regulatory Struggles

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Bambu Lab Shakes Up 3D Printing with Massive Discounts

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...